Successful treatment of atrial tachycardias with flecainide acetate.
- 1 February 1985
- Vol. 53 (2), 164-166
- https://doi.org/10.1136/hrt.53.2.164
Abstract
Intravenous flecainide successfully terminated atrial tachycardia in three patients. Maintenance treatment with oral flecainide prevented the recurrence of tachycardia for up to three years. These results suggest an additional use for flecainide which should be further explored.This publication has 9 references indexed in Scilit:
- Effect of intravenous flecainide on atrial vulnerability in manKlinische Wochenschrift, 1983
- Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassificationCardiovascular Research, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasThe American Journal of Cardiology, 1983
- Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.Heart, 1982
- Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.Circulation, 1982
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Antiarrhythmic effects of flecainideClinical Pharmacology & Therapeutics, 1980
- Antiarrhythmic and Hemodynamic Actions of Flecainide Acetate (R-818) in the Ischemic Porcine HeartJournal of Cardiovascular Pharmacology, 1979